Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/08/2012EP2483281A1 Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
08/08/2012EP2483280A1 New aminoacid derivatives, their process of preparation and their therapeutical uses as inhibitors of oncogenic signals by the met family
08/08/2012EP2483278A1 Benzoxazepin pi3k inhibitor compounds and methods of use
08/08/2012EP2483277A1 Benzoxepin pi3k inhibitor compounds and methods of use
08/08/2012EP2483275A1 HETEROCYCLIC-FUSED PYRAZOLO[4,3-c]PYRIDIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
08/08/2012EP2483274A2 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
08/08/2012EP2483273A1 Novel macrocyclic inhibitors of hepatitis c virus replication
08/08/2012EP2483272A2 Pi3k (delta) selective inhibitors
08/08/2012EP2483271A1 Pyrazoline dione derivatives as nadph oxidase inhibitors
08/08/2012EP2483270A1 Indazole derivatives and their use for blockading voltage dependent sodium channels
08/08/2012EP2483269A2 Polycyclic compounds as lysophosphatidic acid receptor antagonists
08/08/2012EP2483268A1 Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases
08/08/2012EP2483266A1 Compounds for the treatment of dyslipidemia and related diseases
08/08/2012EP2483264A1 Pyrazole derivatives which modulate stearoyl-coa desaturase
08/08/2012EP2483263A1 Novel compounds that are erk inhibitors
08/08/2012EP2483259A1 Irreversible inhibitors useful for the treatment of kinase-related pathologies
08/08/2012EP2483257A2 2,3,4-benzothiadiazepine-2,2-dioxide derivatives
08/08/2012EP2483255A1 Oxazine derivatives and their use in the treatment of neurological disorders
08/08/2012EP2483254A1 Novel compounds
08/08/2012EP2483253A2 Compounds as lysophosphatidic acid receptor antagonists
08/08/2012EP2483252A2 Compounds as lysophosphatidic acid receptor antagonists
08/08/2012EP2483251A2 Polycyclic compounds as lysophosphatidic acid receptor antagonists
08/08/2012EP2483249A1 Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors
08/08/2012EP2483248A1 Crystalline form i rosuvastatin zinc salt
08/08/2012EP2483247A1 New benzimidazole derivatives and their use as fxr agonists
08/08/2012EP2483246A1 Process for preparing biphenyl imidazole compounds
08/08/2012EP2483245A1 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors
08/08/2012EP2483244A1 2-pyridone compounds used as inhibitors of neutrophil elastase
08/08/2012EP2483242A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers
08/08/2012EP2483240A2 1-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
08/08/2012EP2483239A2 Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use
08/08/2012EP2483237A1 Amide derivatives of valproic acid and uses thereof
08/08/2012EP2483233A2 Heteroatom containing substituted fatty acids
08/08/2012EP2483199A2 Silk nanospheres and microspheres and methods of making same
08/08/2012EP2482931A1 Reduced-odor polyol composition and method of producing same
08/08/2012EP2482853A1 Cooperative conveyance of basic active principles by amphiphilic acid molecules
08/08/2012EP2482851A2 Stable, liquid, ready-to-use ketoprofen formulation
08/08/2012EP2482850A2 Topical formulations
08/08/2012EP2482840A2 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
08/08/2012EP2482839A1 Means and methods for treating ischemic conditions
08/08/2012EP2482837A2 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
08/08/2012EP2482826A1 Arabinogalactan for enhancing the adaptive immune response
08/08/2012EP2482825A1 Piscine reovirus diagnostic compositions
08/08/2012EP2482824A1 Piscine reovirus immunogenic compositions
08/08/2012EP2482823A2 Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases
08/08/2012EP2482822A1 Orally administered corticosteroid compositions
08/08/2012EP2482821A1 Crystalline hydrochloride salts of c-met kinase inhibitors
08/08/2012EP2482820A2 New use of pdgfrbeta inhibitors
08/08/2012EP2482819A2 Combination
08/08/2012EP2482818A1 Positively-charged poly (d,l-lactide-co-glycolide) nanoparticles and fabrication methods of the same
08/08/2012EP2482817A1 Methods of treating aneurysmal dilatation, blood vessel wall weakness and specifically abdominal aortic and thoracic aneurysm using matrix metalloprotease-2 inhibitors
08/08/2012EP2482816A1 Topical compositions of opioid antagonists and methods for treating skin conditions therewith
08/08/2012EP2482815A1 Anti inflammatory 2-oxothiazoles and 2 -oxooxazoles
08/08/2012EP2482814A1 Methods and compositions for treatment of ocular fibrosis
08/08/2012EP2482813A1 Salts, solvates, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same
08/08/2012EP2482812A2 Therapeutic uses of pharmaceutical compositions
08/08/2012EP2482811A2 Method and system for accessing patient data
08/08/2012EP2482810A2 Dosage regimen of an s1p receptor modulator
08/08/2012EP2482809A1 Compositions comprising an anti-inflammatory blend
08/08/2012EP2482808A1 A dissolvable film strip comprising natural components
08/08/2012EP2482806A1 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
08/08/2012EP2482803A1 Formulations for c-met kinase inhibitors
08/08/2012EP2482800A1 Cosmetic foam
08/08/2012EP2482799A1 Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
08/08/2012EP2482798A1 Olopatadine compositions and uses thereof
08/08/2012EP2482788A2 Topical tetracycline compositions
08/08/2012EP2482666A2 Gluten-free foodstuff
08/08/2012EP2482661A1 Reversed biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
08/08/2012EP2482659A1 HEXAHYDROCYCLOPENTA[f]INDAZOLE 5-YL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
08/08/2012EP2482658A1 Methods and compositions for treatment of raynaud's phenomenon
08/08/2012EP2482657A1 O-benzyl nicotinamide analogs as mglur5 positive allosteric modulators
08/08/2012EP2334687B9 Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
08/08/2012EP2334284B1 Compacted cinacalcet
08/08/2012EP2321308B9 Piperidine gpcr agonists
08/08/2012EP2285413B1 A pharmaceutical composition
08/08/2012EP2279184B1 Indole modulators of the alpha-7 nicotinic acetylcholine receptor
08/08/2012EP2279183B1 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7
08/08/2012EP2268632B1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors
08/08/2012EP2242752B1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors
08/08/2012EP2201116B1 Means and methods for shrna mediated conditional knockdown of genes
08/08/2012EP2200612B1 Inhibitors of janus kinases
08/08/2012EP2189161B1 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent
08/08/2012EP2181990B1 Piperidine derivative
08/08/2012EP2170297B1 Duloxetine formulation
08/08/2012EP2155231B1 Imaging and therapy of virus-associated tumors
08/08/2012EP2152369B1 Use of fluoride-containing compounds for diagnostic purposes with the help of imaging processes
08/08/2012EP2121693B1 8-oxoadenine derivatives as immuno-modulators
08/08/2012EP2114158B1 3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses
08/08/2012EP2089386B1 Oxazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
08/08/2012EP2068812B9 Medicinal package
08/08/2012EP2057140B1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
08/08/2012EP2041128B1 Substituted gamma lactams as therapeutic agents
08/08/2012EP2035004B1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
08/08/2012EP2029527B1 Modified chalcone compounds as antimitotic agents
08/08/2012EP2004169B1 Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
08/08/2012EP1996554B1 Sigma receptor inhibitors
08/08/2012EP1996207B1 Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome
08/08/2012EP1988776B1 Antiviral drugs for treatment of arenavirus infection
08/08/2012EP1968991B9 Bis-platinum complexes with antitumor activity
08/08/2012EP1966158B1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
1 ... 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 ... 7860